These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 33387395
1. A comparative study of platelet factor 4-enhanced platelet activation assays for the diagnosis of heparin-induced thrombocytopenia. Rubino JG, Arnold DM, Warkentin TE, Smith JW, Kelton JG, Nazy I. J Thromb Haemost; 2021 Apr; 19(4):1096-1102. PubMed ID: 33387395 [Abstract] [Full Text] [Related]
2. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis. Padmanabhan A, Jones CG, Curtis BR, Bougie DW, Sullivan MJ, Peswani N, McFarland JG, Eastwood D, Wang D, Aster RH. Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366 [Abstract] [Full Text] [Related]
7. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT? Warkentin TE, Smythe MA, Ali MA, Aslam N, Sheppard JI, Smith JW, Moore JC, Arnold DM, Nazy I. Am J Hematol; 2021 Mar 01; 96(3):320-329. PubMed ID: 33326124 [Abstract] [Full Text] [Related]
8. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients. Demma LJ, Winkler AM, Levy JH. Anesth Analg; 2011 Oct 01; 113(4):697-702. PubMed ID: 21788317 [Abstract] [Full Text] [Related]
9. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay. Warkentin TE, Arnold DM, Kelton JG, Sheppard JI, Smith JW, Nazy I. Chest; 2018 Jun 01; 153(6):1396-1404. PubMed ID: 29325985 [Abstract] [Full Text] [Related]
10. A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies. Jones CG, Pechauer SM, Curtis BR, Bougie DW, Irani MS, Dhakal B, Pierce B, Aster RH, Padmanabhan A. Chest; 2017 Oct 01; 152(4):e77-e80. PubMed ID: 28991552 [Abstract] [Full Text] [Related]
13. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia. Izban KF, Lietz HW, Hoppensteadt DA, Jeske WP, Fareed J, Bakhos M, Walenga JM. Semin Thromb Hemost; 1999 Oct 01; 25 Suppl 1():51-6. PubMed ID: 10357152 [Abstract] [Full Text] [Related]
15. Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology. Pouplard C, Rollin J, Vayne C, Charuel N, Ahmadi Z, Alberio L, Azjenberg N, Althaus K, Bakchoul T, Chong B, Curtis BR, Faille D, Gomez FJ, Gresele P, Morel-Kopp MC, Mullier F, Nazy I, Smith JW, Greinacher A, Gruel Y. J Thromb Haemost; 2022 Jan 01; 20(1):252-259. PubMed ID: 34657390 [Abstract] [Full Text] [Related]
19. Performance evaluation of heparin-induced platelet aggregation vs serotonin release assay. Barouqa M, Matta M, Reyes-Gil M. Am J Clin Pathol; 2024 Feb 01; 161(2):122-129. PubMed ID: 37936260 [Abstract] [Full Text] [Related]
20. Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance. Rollin J, Charuel N, Gruel Y, Billy S, Guéry EA, May MA, Pouplard C, Vayne C. J Thromb Haemost; 2022 Nov 01; 20(11):2646-2655. PubMed ID: 35971886 [Abstract] [Full Text] [Related] Page: [Next] [New Search]